Robust hepatitis B virus genotyping by mass spectrometry.
Genotyping of hepatitis B virus (HBV) is important for tracking HBV infections, prognosticating the development of severe liver disease, and predicting outcomes of therapy. Current genotyping methods can be laborious and costly and rely on subjective data interpretation. To identify less expensive but equally reliable alternatives, we compared "gold standard" sequencing to a novel mass spectrometry approach. Sera from individuals with acute or chronic HBV infection (n = 756), representing all genotypes, were used to PCR amplify the HBV S gene. All amplicons were subjected to base-specific cleavage and matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS). The resulting mass peak patterns were used to identify HBV genotype by automated comparison to peak patterns simulated from reference sets of HBV sequences of known genotypes. The MALDI-TOF MS data and phylogenetic analysis of HBV sequences produced completely concordant results. Several parameters such as genetic relatedness of tested HBV variants to the reference set, chronic infections, and the quality of PCR products can lower the MS score but never affected the accuracy of the genotype call. This new streamlined MS-based method provides for rapid and accurate HBV genotyping, produces automated data reports, and is therefore suitable for routine use in diagnostic settings.
Ganova-Raeva
L
L
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, USA. lkg7@cdc.gov
Ramachandran
S
S
Honisch
C
C
Forbi
J C
JC
Zhai
X
X
Khudyakov
Y
Y
D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D005838:Genotype; D006509:Hepatitis B / Q000821:virology*; D006515:Hepatitis B virus / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D010802:Phylogeny; D016133:Polymerase Chain Reaction; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*; D014773:Virology / Q000379:methods*
D004279:DNA, Viral
Jpn J Infect Dis. 2003 Feb;56(1):19-22
12711821
Nucleic Acids Res. 2005 Feb 24;33(4):e38
15731331
J Clin Microbiol. 2006 Aug;44(8):2792-800
16891494
J Chemother. 2005 Oct;17(5):514-20
16323440
J Virol Methods. 2008 Aug;151(2):217-24
18571738
Clin Liver Dis. 2007 Nov;11(4):761-95, viii
17981228
Arch Virol. 2008;153(11):2019-25
18836856
J Infect Dis. 1997 Jun;175(6):1285-93
9180165
New Microbiol. 2008 Apr;31(2):189-94
18623983
Bull Exp Biol Med. 2009 Feb;147(2):220-5
19513426
Am J Ther. 2007 May-Jun;14(3):306-9
17515708
J Clin Microbiol. 1993 May;31(5):1095-102
8501209
World J Gastroenterol. 2007 Jan 7;13(1):14-21
17206751
Virus Res. 2002 Jan 30;82(1-2):65-71
11885953
J Hepatol. 1999 May;30(5):749-54
10365797
Genome Res. 2004 Jan;14(1):126-33
14707174
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10649-54
17563374
J Clin Microbiol. 2003 Dec;41(12):5473-7
14662927
J Clin Virol. 2005 Oct;34(2):155-7
16023890
World J Gastroenterol. 2007 Apr 7;13(13):1975-9
17461500
J Clin Microbiol. 2006 Oct;44(10):3600-7
17021089
Clin Chem. 2009 Aug;55(8):1503-9
19541863
J Virol. 2002 Jun;76(12):6131-7
12021346
Hepatology. 2001 Oct;34(4 Pt 1):817-23
11584381
Malays J Pathol. 2007 Dec;29(2):79-90
19108399
J Infect Dis. 2009 May 1;199(9):1275-85
19301976
J Clin Gastroenterol. 2005 Aug;39(7):611-8
16000930
J Gen Virol. 2008 Dec;89(Pt 12):3009-3015
19008387
J Clin Virol. 2006 Nov;37(3):218-21
16973411
Arch Virol. 1998;143(12):2313-26
9930189
Antivir Ther. 2003 Dec;8(6):627-34
14760897
Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):457-64
18842489
J Clin Virol. 2005 Dec;34 Suppl 1:S4-8
16461222